
CSX · Nasdaq
Consensus is Buy across all 24 analysts, with a mean price target of $54. The low and high targets are not available, so the target cluster and width of dispersion cannot be measured. The supplied evidence does not identify which analyst is most bullish or least bullish, and it reports no named-bank targets or rating changes. It also provides no revisions during the past week, so the direction of estimate or target changes cannot be established. The substantive disagreement behind any target spread is therefore unavailable; the observable contrast is between uniformly positive ratings and CSX’s fiscal 2025 declines in revenue to $14.1 billion and net income to $2.9 billion.